CD19 and acute myeloid leukemia: EV phenotyping showed that EVs, derived from both KG-1 and ME-1 AML cell lines, resulted positive for AML markers, like CD33, CD34 and CD38; instead, they resulted negative for CD14, CD19 and CD117 antigens (Figures 1D, E).